StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]
Aldeyra Therapeutics (ALDX) Outperform Rating Reaffirmed at Oppenheimer theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aldeyra Therapeutics (NASDAQ:ALDX) Earns Buy Rating from HC Wainwright wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc purchased 37,712 shares of the stock in a transaction dated Friday, April 5th. The shares were acquired at an average price of $4.74 per share, with a total value of $178,754.88. Following the completion of the acquisition, the insider now owns 9,275,851 […]
Oppenheimer upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Wednesday morning, MarketBeat reports. They currently have $10.00 target price on the biotechnology company’s stock. ALDX has been the subject of several other research reports. StockNews.com upgraded Aldeyra […]